Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Xenon Pharmaceuticals Inc.”

102 pharma patents match "Xenon Pharmaceuticals Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 102
Index total 30,257
Page 1 / 5

Quick answer

This filtered view shows 102 pharmaceutical patents matching "Xenon Pharmaceuticals Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

102 results for “Xenon Pharmaceuticals Inc.” · 30,257 patents in full index Clear search

  1. US 12319657

    Solid state crystalline forms of a selective potassium channel modulator

    Xenon Pharmaceuticals Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  2. US 12178811

    Methods of treating depressive disorders

    Xenon Pharmaceuticals Inc. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  3. US 12171759

    Methods and uses for treating anhedonia

    Xenon Pharmaceuticals Inc. · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  4. US 11957675

    Methods and uses for treating anhedonia

    Xenon Pharmaceuticals Inc. · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  5. US 11325902

    Benzenesulfonamide compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted May 10, 2022 · Expires May 5, 2042

    granted
  6. US 11299490

    Benzenesulfonamide compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted
  7. US 11203572

    Substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  8. US 11174268

    Benzenesulfonamide compouds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  9. US 11149002

    Therapeutic compounds and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  10. US 11135214

    Methods for enhancing the bio availability and exposure of a voltage-gated potassium channel opener

    Xenon Pharmaceuticals Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted
  11. US 11130726

    Therapeutic compounds and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted
  12. US 11091441

    Solid state crystalline forms of a selective potassium channel modulator

    Xenon Pharmaceuticals Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  13. US 10899732

    Substituted benzamides useful as sodium channel blockers

    Xenon Pharmaceuticals Inc. · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted
  14. US 10815229

    Benzenesulfonamide compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  15. US 10787446

    Therapeutic compounds and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  16. US 10766858

    Substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  17. US 10752623

    Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors

    Xenon Pharmaceuticals Inc. · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  18. US 10745392

    Benzenesulfonamide compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  19. US 10662184

    Benzenesulfonamide compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted May 26, 2020 · Expires May 21, 2040

    granted
  20. US 10526285

    Therapeutic compounds and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted
  21. US 10513526

    Solid state forms of spiro-oxindole compounds

    Xenon Pharmaceuticals Inc. · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted
  22. US 10457654

    Therapeutic compounds and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted
  23. US 10246453

    Benzenesulfonamide compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted
  24. US 10179767

    Substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted